MONTHLY ARCHIVE
January 2022 Market News Archive
5 news stories from January 2022, aggregated by Catalayer from 50+ global sources.
Incyte pulls FDA filing for cancer drug approval over confirmatory study, following Gilead out of the exit - Fierce Biotech
2022-01-26
A biotech wins the first FDA drug approval in a rare type of eye cancer - BioPharma Dive
2022-01-26
Johnson & Johnson Reports Q4 and Full-Year 2021 Results - Johnson & Johnson
2022-01-25
In the Craze for Unicorns and IPO Valuations, Do Not Take Retail Investor for a Ride - News18
2022-01-22
BNY Mellon Investment Funds - Newton Multi-Asset Balanced Fund T Accumulation - Financial Times
2022-01-19
Ready to explore Catalayer?
Explore the platform, or bring us your next product idea.